MeSH term
Frequency | Condition_Probility | Humans | 131 | 0.0 |
Animals | 95 | 0.0 |
Female | 28 | 0.0 |
Male | 21 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 109 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 66 | 0.0 |
Aquaporins/*genetics/*metabolism | 4 | 57.0 |
Kidney/*physiology | 4 | 9.0 |
Mice | 25 | 0.0 |
Mice, Transgenic | 4 | 0.0 |
Aquaporins/chemistry/*metabolism | 4 | 80.0 |
Biological Transport/physiology | 3 | 1.0 |
Permeability | 13 | 8.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 7 | 0.0 |
Water/metabolism | 16 | 23.0 |
Protein Conformation | 12 | 0.0 |
Tissue Distribution | 10 | 0.0 |
Water/*metabolism | 24 | 51.0 |
Amino Acid Sequence | 23 | 0.0 |
Aquaporins/chemistry/*genetics/*metabolism | 2 | 50.0 |
Base Sequence | 17 | 0.0 |
Cloning, Molecular | 12 | 0.0 |
Molecular Sequence Data | 33 | 0.0 |
Oocytes/physiology | 7 | 5.0 |
Sequence Alignment | 4 | 0.0 |
Xenopus | 5 | 0.0 |
Binding Sites | 2 | 0.0 |
Infant | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Cell Membrane/chemistry | 2 | 1.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Comparative Study | 11 | 0.0 |
Immunohistochemistry | 22 | 0.0 |
Microscopy, Immunoelectron | 11 | 2.0 |
Rats | 27 | 0.0 |
Aquaporins/*biosynthesis | 2 | 66.0 |
Blotting, Northern | 5 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Mice, Inbred Strains | 2 | 0.0 |
Phenotype | 7 | 0.0 |
Aquaporins/*chemistry | 4 | 80.0 |
Crystallography, X-Ray | 6 | 0.0 |
Protein Structure, Tertiary/physiology | 2 | 1.0 |
Water-Electrolyte Balance/*physiology | 4 | 11.0 |
Aquaporins/*genetics/metabolism | 3 | 37.0 |
Cell Line | 6 | 0.0 |
Hypertonic Solutions | 2 | 14.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Homeostasis | 3 | 0.0 |
Osmolar Concentration | 9 | 1.0 |
Cell Membrane/metabolism | 5 | 0.0 |
DNA Primers | 3 | 0.0 |
Cell Membrane/*metabolism | 2 | 0.0 |
Cell Membrane Permeability/drug effects/physiology | 2 | 25.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Biological Transport | 11 | 0.0 |
Models, Molecular | 14 | 0.0 |
Sequence Homology, Amino Acid | 10 | 0.0 |
Structure-Activity Relationship | 4 | 0.0 |
Adult | 11 | 0.0 |
Capillary Permeability/*physiology | 2 | 15.0 |
Case-Control Studies | 2 | 0.0 |
Middle Aged | 10 | 0.0 |
Immunoblotting | 11 | 0.0 |
Kidney/metabolism | 3 | 0.0 |
Lung/metabolism | 4 | 2.0 |
*Membrane Proteins | 7 | 0.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Rats, Wistar | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 12 | 0.0 |
Skin/metabolism | 2 | 1.0 |
Body Water/metabolism | 6 | 18.0 |
Molecular Conformation | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Blotting, Western | 14 | 0.0 |
Erythrocytes/*metabolism | 3 | 1.0 |
Escherichia coli/metabolism | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Freeze Fracturing | 3 | 13.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Microscopy, Electron | 4 | 0.0 |
Microscopy, Fluorescence | 5 | 0.0 |
Oocytes/metabolism | 5 | 2.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Protein Structure, Quaternary | 3 | 1.0 |
Time Factors | 3 | 0.0 |
Xenopus laevis | 20 | 4.0 |
Aquaporins/genetics/*metabolism | 12 | 54.0 |
Cells, Cultured | 9 | 0.0 |
Gene Expression Regulation | 5 | 0.0 |
Osmotic Pressure | 2 | 3.0 |
RNA, Messenger/analysis | 8 | 0.0 |
Up-Regulation | 3 | 0.0 |
Cell Membrane Permeability | 16 | 10.0 |
Electrostatics | 2 | 1.0 |
*Escherichia coli Proteins | 5 | 2.0 |
Glycerol/metabolism | 5 | 12.0 |
Kinetics | 8 | 0.0 |
Lipid Bilayers | 3 | 7.0 |
Models, Biological | 2 | 0.0 |
Protein Structure, Secondary | 3 | 0.0 |
Protons | 3 | 3.0 |
Thermodynamics | 4 | 1.0 |
Aquaporins/metabolism | 6 | 85.0 |
Fibroblast Growth Factor 2/metabolism | 2 | 2.0 |
Immunoenzyme Techniques | 3 | 0.0 |
Prognosis | 2 | 0.0 |
4-Chloromercuribenzenesulfonate/pharmacology | 3 | 33.0 |
DNA, Complementary | 5 | 0.0 |
Fundulidae | 2 | 66.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
Mammals | 2 | 0.0 |
Mercuric Chloride/pharmacology | 3 | 23.0 |
Genotype | 2 | 0.0 |
Infant, Newborn | 5 | 0.0 |
Pedigree | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Gene Expression | 4 | 0.0 |
Kidney Tubules, Proximal/*metabolism | 2 | 16.0 |
*Phylogeny | 2 | 1.0 |
Adolescent | 2 | 0.0 |
Aged | 7 | 0.0 |
Aquaporins/*physiology | 5 | 71.0 |
*Cell Membrane Permeability | 2 | 8.0 |
Erythrocyte Membrane/metabolism | 2 | 3.0 |
Aged, 80 and over | 2 | 0.0 |
*Peritoneal Dialysis | 4 | 6.0 |
DNA Primers/genetics | 2 | 0.0 |
In Vitro | 8 | 0.0 |
RNA, Messenger/genetics/metabolism | 4 | 0.0 |
Osmosis | 5 | 19.0 |
Patch-Clamp Techniques | 2 | 0.0 |
Rabbits | 2 | 0.0 |
Aquaporins/chemistry/*genetics | 2 | 40.0 |
Phylogeny | 3 | 0.0 |
Aquaporins/*metabolism | 15 | 46.0 |
Brain/*metabolism | 2 | 0.0 |
English Abstract | 7 | 0.0 |
Nitric-Oxide Synthase/*metabolism | 2 | 2.0 |
Treatment Failure | 2 | 0.0 |
Ultrafiltration | 2 | 3.0 |
Body Water/physiology | 4 | 50.0 |
Crystallography/methods | 2 | 50.0 |
Protein Folding | 2 | 0.0 |
Aquaporins/biosynthesis/*genetics | 2 | 100.0 |
Microscopy, Confocal | 5 | 0.0 |
Oocytes | 5 | 4.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
Sodium/metabolism | 3 | 2.0 |
Crystallization | 5 | 2.0 |
Escherichia coli/*chemistry | 2 | 25.0 |
Microscopy, Atomic Force | 2 | 9.0 |
Shadowing (Histology) | 2 | 66.0 |
Surface Properties | 2 | 1.0 |
Mice, Knockout | 6 | 0.0 |
Kidney/*metabolism | 5 | 2.0 |
Mutagenesis, Site-Directed | 6 | 0.0 |
Oocytes/drug effects/metabolism | 3 | 17.0 |
Permeability/drug effects | 2 | 8.0 |
Calcium/*metabolism | 2 | 0.0 |
Cattle | 9 | 0.0 |
Hydrogen-Ion Concentration | 4 | 0.0 |
Ion Channels/*metabolism | 7 | 17.0 |
Lens, Crystalline/metabolism | 2 | 18.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Cyclic GMP/*metabolism | 2 | 5.0 |
Insects | 2 | 1.0 |
Ion Channel Gating | 2 | 2.0 |
Conserved Sequence | 2 | 0.0 |
Glycosylation | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Aquaporins/*pharmacology | 2 | 100.0 |
Digestive Physiology | 2 | 8.0 |
Transfection | 3 | 0.0 |
Cell Membrane Permeability/*physiology | 2 | 22.0 |
*Membrane Glycoproteins | 4 | 0.0 |
Crystallography | 2 | 6.0 |
Molecular Weight | 2 | 0.0 |
Water | 2 | 3.0 |
Ion Channels/*physiology | 3 | 9.0 |
Aquaporins/*genetics | 2 | 11.0 |
In Situ Hybridization | 4 | 0.0 |
RNA/analysis | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Body Water/*metabolism | 2 | 8.0 |
Pregnancy | 3 | 0.0 |
Biological Transport, Active | 2 | 1.0 |
Diffusion | 2 | 2.0 |
Fluorescent Dyes | 2 | 0.0 |
Genetic Vectors | 3 | 0.0 |
Recombination, Genetic | 2 | 0.0 |
Erythrocyte Membrane/*metabolism | 2 | 2.0 |
Sheep | 3 | 0.0 |
*Aquaporins | 33 | 43.0 |
Adenoviridae/genetics | 2 | 0.0 |
Ion Channels/genetics/*metabolism | 2 | 9.0 |
Glycerol/*metabolism | 4 | 36.0 |
Ion Channels/*genetics | 5 | 11.0 |
Age Factors | 3 | 0.0 |
Gene Expression Regulation, Developmental | 3 | 0.0 |
Urea/metabolism | 3 | 6.0 |
Mercuric Chloride/*pharmacology | 2 | 40.0 |
RNA, Complementary | 2 | 14.0 |
Renal Dialysis | 2 | 0.0 |
Calorimetry | 2 | 3.0 |
Brain/metabolism | 4 | 0.0 |
Eye/metabolism | 3 | 21.0 |
Mutation | 4 | 0.0 |
Body Weight | 2 | 0.0 |
Phloretin/pharmacology | 2 | 20.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Cell Membrane Permeability/drug effects | 2 | 3.0 |
Mice, Inbred BALB C | 2 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
*Chromosomes, Human, Pair 7 | 2 | 0.0 |
Carbonic Anhydrases/metabolism | 2 | 14.0 |
Aquaporins/*analysis | 2 | 33.0 |
Rats, Sprague-Dawley | 3 | 0.0 |
Water-Electrolyte Balance/physiology | 2 | 5.0 |
*Water-Electrolyte Balance | 2 | 4.0 |
